Fundraising Fox
Cambridge
Cambridge, GB · 1 known investors
Find your way into Cambridge
Sign up to see every warm intro you have to Cambridge
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Cambridge team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Cambridge Nucleomics develops a single-molecule RNA counting "nanoarray" assay based on solid-state nanopore and DNA nanotechnology for diagnostic testing. The company applies its technology to RNA biology and microbiology-based diagnostics.
Founders & leadership
HR
Hendrik RungeFounder & CEOHendrik Runge holds a Bachelor's and Master's in Molecular Medicine from Freiburg, Germany, and completed a PhD in Medical Research at Cambridge University focusing on lymphoma research, where he worked with CRISPR/Cas9 and primary human cell cultures. He is Founder and CEO of Cambridge Nucleomics, which develops RNA analysis tools for diagnostics, and previously worked with the healthcare accelerator Start Codon.
Board
AC
Anthony CookeChairman
JY
John YeomansBoard director
MZ
Max ZhuBoard director
Investors · 1
Frequently asked questions
- What does Cambridge do?
- Cambridge Nucleomics develops a single-molecule RNA counting "nanoarray" assay based on solid-state nanopore and DNA nanotechnology for diagnostic testing. The company applies its technology to RNA biology and microbiology-based diagnostics.
- Who founded Cambridge?
- Cambridge was founded by Hendrik Runge, Ulrich Keyser.
- Who are Cambridge's investors?
- Cambridge's investors include Cambridge Angels group.
- Where is Cambridge headquartered?
- Cambridge is headquartered in Cambridge, GB.